Nurse Practitioner, Adult Health · New Haven, CT
NPI
1689985715
Since 2010
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
40 Temple St, Suite 1a
New Haven, CT, 06510
Phone (203) 785-4138
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
201 services
Medicare patients, 2024
141
Average age 69
Drug cost, 2024
$547K
455 prescriptions
Company payments, 2025
$1,793
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristine M Drozd was code 91200 (standard x-ray), 97 times for 96 patients. In total Kristine M Drozd billed 201 services in 7 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91200 Standard X-ray | Office | 97 | 96 | $18.36 | $1,781 |
| 99214 Office E&M - Established | Office | 71 | 46 | $85.23 | $6,051 |
| 99215 Office E&M - Established | Office | 23 | 20 | $103.54 | $2,381 |
By year: 2022 $12K for 196 services; 2023 $11K for 183 services; 2024 $11K for 201 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristine M Drozd prescribed most often to Medicare patients was Ozempic (Semaglutide), with 108 prescriptions and refills. In total Kristine M Drozd wrote 455 Medicare prescriptions that cost $547K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 108 | 125 | 17 | $111K |
| Vemlidy Tenofovir Alafenamide | 47 | 47 | Under 11 | $69K |
| Xifaxan Rifaximin | 29 | 29 | Under 11 | $96K |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 28 | 28 | Under 11 | $222K |
| Metformin Hcl Generic | 28 | 38 | 11 | $78.3 |
| Metformin Hcl Er Metformin Hcl | 25 | 36 | Under 11 | $117 |
| Nadolol Generic | 25 | 43 | Under 11 | $1,783 |
| Famotidine Generic | 19 | 27 | Under 11 | $185 |
| Entecavir Generic | 17 | 45 | Under 11 | $8,739 |
| Lactulose Generic | 12 | 14 | Under 11 | $1,473 |
| Carvedilol Generic | 12 | 16 | Under 11 | $142 |
| Trulicity Dulaglutide | 11 | 11 | Under 11 | $11K |
| Budesonide Ec Budesonide | 11 | 11 | Under 11 | $616 |
| Azathioprine Generic | 11 | 11 | Under 11 | $855 |
| Tenofovir Disoproxil Fumarate Generic | 11 | 31 | Under 11 | $6,087 |
Brand drugs: 239 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristine M Drozd $1,793 ($1,793 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $1,155.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.